Retatrutide
(GLP-1 / GIP / Glucagon Triple Agonist)
Retatrutide is an advanced investigational peptide currently being studied for its multi-receptor activity on metabolic regulation, energy balance, and body composition. As a triple agonist, it targets three key hormonal pathways involved in nutrient sensing and homeostasis. Current areas of research interest include:
-
Weight Reduction and Body Recomposition
Retatrutide is under investigation for its effects on fat mass reduction, lean mass preservation, and whole-body energy balance. -
Appetite and Satiety Signaling
Researchers are evaluating its impact on hunger suppression, delayed gastric emptying, and altered food reward behavior. -
Glucose and Lipid Metabolism
The compound is being studied for its ability to influence insulin sensitivity, glycemic control, and lipid profiles.
How It Works
Retatrutide is a triple agonist that simultaneously activates the GLP-1, GIP, and glucagon receptors, three hormone systems deeply involved in energy intake and expenditure. GLP-1 and GIP promote insulin secretion and satiety, while glucagon receptor activation may increase energy expenditure and promote lipolysis. This multifaceted approach is designed to harness both anabolic and catabolic signals, making Retatrutide a unique compound of interest in obesity and metabolic research.
⚠️ Important Notice:
This product is sold strictly for laboratory research purposes only. It is not for human or animal use, and not for therapeutic or diagnostic applications.
By purchasing, you confirm that you are a qualified individual using this product in accordance with all applicable laws and research regulations.
